Olpasiran
id:
olpasiran-320-10658618
title:
Olpasiran
text:
Olpasiran (AMG890) is an experimental antisense therapy designed to lower the level of lipoprotein(a), which is believed to be a causal factor in the development of cardiovascular disease. The drug is developed by Amgen.
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Olpasiran
date created:
date modified:
2024-01-17T01:20:22Z
main entity:
{"identifier":"Q123699686","url":"https://www.wikidata.org/entity/Q123699686"}
image:
fields total:
13
integrity:
13